Crescent Biopharma (CBIO) Interest Coverage Ratio (2024 - 2025)

Crescent Biopharma (CBIO) reported Interest Coverage Ratio of 19.6 for Q2 2025, down 53.22% quarter-over-quarter from 12.79 in Q1 2025.

Crescent Biopharma (CBIO) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

Crescent Biopharma (CBIO) has 2 years of Interest Coverage Ratio data on file, last reported at 19.6 in Q2 2025.

Interest Coverage Ratio for Q2 2025 came in at 19.6, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 152.04 (down 572.47% YoY), and the FY2025 annual result was 69.85, changed N/A from the prior year.
Interest Coverage Ratio declined to 19.6 in Q2 2025 per CBIO's latest filing, from 12.79 in the prior quarter.
Over five years, Interest Coverage Ratio peaked at 12.79 in Q1 2025 and troughed at 20.18 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Crescent Biopharma	486.92 Mn	297.76 Mn	-	-

Download Data